ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EU approves Camurus’s Buvidal injections to treat opoid dependency
pharmaceutical-technology
November 25, 2018Swedish research-based pharmaceutical and biotechnology company Camurus has received European Commission (EC) approval for weekly and monthly Buvidal injections to treat opioid dependency in adults and teenagers from 16 years of age. -
EU approves Camurus’s Buvidal injections to treat opoid dependency
pharmaceutical-technology
November 25, 2018Swedish research-based pharmaceutical and biotechnology company Camurus has received European Commission (EC) approval for weekly and monthly Buvidal injections to treat opioid dependency in adults and teenagers from 16 years of age.
Pharma Sources Insight January 2025
